Columnist Betty Vertin doesn't often dwell on her caregiver grief, but sometimes she needs to embrace it and let it flow through her.

In a $12 billion deal, Novartis has agreed to acquire Avidity Biosciences, which is developing several treatments for ...

As columnist Robin Stemple's FSHD progresses, he worries about how his increased care needs will affect his family caregivers ...

Learning how to talk to doctors about Duchenne muscular dystrophy can help support you in your role as a caregiver for ...

Bridgebio Pharma says it will seek U.S. approval of BBP-418 for LGMD2i after Phase 3 trial data showed a range of benefits ...